RxDoctor Payments DataLook up a doctor →

Ashley Larsen, PA

Medical · Ocean Springs, MSNPI 1144301458

Payments from drug & device makers

$10,626in general payments, 2019–2025

Across 527 payments — averaging $20.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$2K
  • AstraZeneca$1K
  • Inspire Medical Systems, Inc.$1K
  • Actelion Pharmaceuticals US, Inc.$970
  • Boehringer Ingelheim$883
  • United Therapeutics Corporation$651
  • plus $4K from 35 others

What the payments were for

  • Travel & lodging$6856%
  • Food & beverage$9,83393%
  • Education$1081%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,626 in reported general payments places this provider in the 95th percentile of 65 medical providers in Mississippi.

See all medical providers in Mississippi

Medicare billing

Part B allowed, 2024
$35,895
Medicare patients
412
Services billed
509

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter147$121,584
Breztri AerosphereBudesonide/Glycopyr/Formoterol52$36,912
Breo ElliptaFluticasone/Vilanterol69$30,889
Spiriva RespimatTiotropium Bromide30$24,179
Stiolto RespimatTiotropium Br/Olodaterol Hcl14$7,312
SymbicortBudesonide/Formoterol Fumarate21$6,193
Combivent RespimatIpratropium/Albuterol Sulfate12$5,746
Albuterol Sulfate HfaAlbuterol Sulfate139$4,528
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$2,228
Montelukast Sodium78$1,150
Fluticasone Propionate97$1,012
Modafinil11$844
Azithromycin28$172
Levocetirizine Dihydrochloride20$84
Prednisone38$58

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$1,567$152,472216 claims
AstraZenecaBreztri Aerosphere, Symbicort$1,146$43,10573 claims
Boehringer IngelheimSpiriva Respimat, Stiolto Respimat, Combivent Respimat$883$37,23656 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 65 medical providers in Mississippi.

Other medical in Ocean Springs

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →